Navigation Links
FDA Accepts Tasimelteon New Drug Application For Priority Review In The Treatment Of Non-24-Hour Disorder In The Totally Blind
Date:7/29/2013

s adverse events were deemed unrelated to study drug and the rates between tasimelteon and placebo treated patients were similar (1.6%, 1.5%).

About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.  For more on Vanda, please visit http://www.vandapharma.com.  

Company Contact:
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

Media Contact:
Laney Landsman
Assistant Vice President
Makovsky
(212) 508-9643
llandsman@makovsky.com

CAUTIONARY NOTE REGARDING FORWWARD LOOKING STATEMENTS
Various statements in this release are "forward-looking statements" under the securities laws.  Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "project," "target," "goal," "likely," "will," "would," and "could," or the negative of these terms and similar expressions or words, identify forward-looking statements.  Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties.  Important factors that could cause actual results to differ materially from those reflected in the company's forward-looking statements include, among others: Vanda's failure to obtain, or any delay in obtaining, regulatory approval for tasimelteon for the treatment of Non-24-Hour Disorder or to comply with ongoing regulatory requirements and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
2. FDA Accepts Takeda and Lundbecks Submission of the New Drug Application for Vortioxetine for the Treatment of Major Depressive Disorder
3. FDA Accepts Novens NDA For An Investigational Nonhormonal Therapy For Menopausal Vasomotor Symptoms
4. Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
5. Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
6. Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
7. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
8. Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
9. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
10. EPGL Medical Invents Self Powered Contact Lenses for Medical and Consumer Applications
11. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Calif. , Aug. 31, 2015   Sanofi ... life sciences team at Google announced today that they ... with type 1 and type 2 diabetes. The collaboration ... expertise in analytics, miniaturized electronics and low power chip ... care by developing new tools that bring together many ...
(Date:8/31/2015)... Aug. 31, 2015  AMRI (NASDAQ: AMRI ... strategic collaboration focused on the development, manufacture and ... ingredients, ("APIs"). The collaboration combines Saneca,s strength in ... in developing and manufacturing controlled substance APIs with ... transfer processes into these facilities. The collaboration will ...
(Date:8/31/2015)...  QT Vascular Ltd., together with its subsidiaries ... its subsidiaries, the "Group"), a global company engaged ... therapeutic solutions for the minimally invasive treatment of ... the below-the-knee ("BTK") cohort of patients in the ... on August 15, 2015 at the 5th Annual ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 2AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 3AMRI Announces Agreement with Saneca Pharmaceuticals, a.s. for Portfolio of Opium-Derived Active Pharmaceutical Ingredients 4Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... Calif., Jan. 18, 2011 Accuray Incorporated (Nasdaq: ... of radiosurgery, announced today that Eric Pauwels has joined Accuray ... 17, 2011. Pauwels is a global industry leader ... top-tier U.S. and European bio-pharmaceutical companies. He has successfully developed ...
... today that TMC , a global, integrated media ... has named the Cardiocom Commander® Telehealth System as a ... Cardiocom,s Commander Telehealth System provides an opportunity ... patient through an interactive "health check" that includes the ...
Cached Medicine Technology:Accuray Hires Chief Marketing Officer 2Accuray Hires Chief Marketing Officer 3Accuray Hires Chief Marketing Officer 4Cardiocom® Receives the 2010 TMCnet Smart Health Excellence Award for its Telehealth System 2Cardiocom® Receives the 2010 TMCnet Smart Health Excellence Award for its Telehealth System 3
(Date:8/31/2015)... , ... August 31, 2015 , ... ... giving potential patients the resources they need to have a successful cosmetic procedure; ... certified plastic surgeons; Cosmetic Town Journal is always ready to help. , It ...
(Date:8/31/2015)... Los Angeles, CA (PRWEB) , ... August 31, 2015 , ... ... August 16 by CDA Press, the expert guest author addressed the topic of treating ... The author explained that, while steroids were shown to slightly improve physical function in ...
(Date:8/31/2015)... ... 31, 2015 , ... The 2015 New York Regional ... family members, medical professionals, and researchers, covering a variety of topics related to ... collaborative effort between the Mesothelioma Applied Research Foundation and Memorial Sloan ...
(Date:8/31/2015)... ... , ... The Bay Pines VA Healthcare System (VAHCS) remains focused ... more doctors and nurses and expanding existing facilities and services. Spine surgery will ... Anthony Jabre was selected to lead and grow the Bay Pines VAHCS’s new spine ...
(Date:8/31/2015)... Plains, NJ (PRWEB) , ... August 31, 2015 ... ... the Joint Replacement Surgery Program at Monmouth, was one of the first doctors ... decade, the results of this new approach have been impressive: faster recovery, decreased ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town: A One Stop Plastic Surgery Community 2Health News:Article on Steroid Use for Back Pain Highlights the Effectiveness of Surgery in Treating Disk Pain, says Dr. Seyed M. Rezaian 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4
... UK it was found that de- addiction drug help to ... people with Naltrexone//. This drug blocks craving for any sort ... of the American Medical Association. This drug can be ... the number of alcohol addicts. The two drugs that were ...
... It is a generally accepted fact that the doses ... but it is not always clear, how much is ... Hopkins Children’s Center shows that making the dosage a ... as well. ,An online infusion calculator and ...
... Idiopathic pulmonary fibrosis (IPF) is a disease whose cause and ... treatment for it till date//. It is a lung disease ... deterioration of the entire organ (lung). Statistics show ... new cases are diagnosed every year. Ten years ago ...
... form of immune-system protein, cyclophilin A, changes the shape of ... is found in HIV-1 when the virus attacks human and ... ,The researchers, who infected cells from Old World monkeys ... the virus particles, reports the latest issue of New Scientist. ...
... are increasingly orienting themselves to video games, highlights a ... firm//. ,According to the poll conducted on ... admitted that they enjoyed video games. This approximates to ... sampling error as well. ,Most adults either ...
... Club gathered in a central Taipei square Sunday to share ... ,Led by founder Chen Dar-cheng, the club members and their ... laughs with names like lion laugh, milkshake laugh and inner ... one club member, wearing a doctor's white gown and holding ...
Cached Medicine News:Health News:Dispensing Drug Dosage To Children Through Computers 2Health News:Dispensing Drug Dosage To Children Through Computers 3Health News:Dispensing Drug Dosage To Children Through Computers 4Health News:Lesser Know Facts about Idiopathic Pulmonary Fibrosis (IPF) 2Health News:Taiwanese Had A Hearty Laugh On World Laughter Day 2
The Natural Selection family of specialty allografts is spinal concepts response to surgeon requests for spinal allograft devices to eliminate the need for painful autograft harvesting....
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
Medicine Products: